News
-
-
-
-
PRESS RELEASE
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
BioVersys receives US FDA green light for BV100 HABP/VABP Phase 3 pivotal trial start to address CRABC infections in hospital-acquired bacterial pneumonia. A significant step in developing novel antibacterial products for MDR bacteria -
-
PRESS RELEASE
85% of banks’ corporate clients plan to engage with a non-bank financial institution within the next year as competition with private capital intensifies
85% of banks' corporate clients plan to engage with non-bank financial institutions in the next year as competition intensifies. Capgemini's report emphasizes the need for CIBs to innovate through technology and culture -
-
-
PRESS RELEASE
SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
SINOPEC Engineering (Group) Co., Ltd. announces annual results for 2025 with RMB70.074 billion in revenue and RMB1.807 billion in net profit, focusing on high-quality development, international operations, and technological innovation -
